Proof of Usefulness Report

Yama Sciences

Analysis completed on 3/8/2026

+195

Proof of Usefulness Score

Gaining Momentum

Yama Sciences addresses a genuine, high-value problem in the pharmaceutical industry (automating compliant content creation). However, the submission contains significant inaccuracies: the audience is strictly B2B (not 'everyone'), and the traction claim that 'most people have used my product' is demonstrably false for a niche life sciences tool. Independent verification confirms the company exists, was founded in 2024, and raised ~$100K in accelerator funding (Forum Ventures) with a small team. While the technology is promising, the score is heavily penalized by the unrealistic claims in the submission.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+75

Audience Reach Impact+20

Technical Innovation+65

Evidence Of Traction+30

Market Timing Relevance+70

Functional Completeness+10

Subtotal+177

Usefulness Multiplierx1.1

Final Score+195

Project Details

Project URL

yamasciences.com

Description

Yama Sciences is an AI company in life sciences, dedicated to enhancing content evaluation and generation. Our platform integrates advanced AI, data analytics, and industry expertise to empower commercial teams. Yama provides deep insights through detailed brand analysis, competition analysis, and localization generation, ensuring compliance and effectiveness throughout the entire customer journey.

Algorithm Insights

Market Position

Growing utility with room for optimization

User Engagement

Documented reach suggests active user community

Technical Stack

Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline